HIV antibody opens up new approaches for vaccine development and combination therapies
|
HIV-1
can be neutralized by antibodies which bind to vulnerable structures on the
virus surface. One such vulnerable site is the so-called V3 glycan ... |
New approach to HIV treatment offers hope to reduce daily drug needs
More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control, according to the ... View article...